AstraZeneca buys worldwide rights to cancer drug for USD1.5 billion
(Alliance News) - AstraZeneca PLC on Tuesday said it has entered into a deal to license a lung cancer therapy, in a deal worth up to USD1.5 billion. Read More
| Price | 12,364.00p on 15-07-2026 at 06:25:02 |
|---|---|
| Change | 0.00p 0% |
| Buy | 12,800.00p |
| Sell | 12,100.00p |
| Last Trade: | Unknown 11.00 at 12,438.75785p |
| Day's Volume: | 16 |
| Last Close: | 12,364.00p |
| Open: | 0.00p |
| ISIN: | GB0009895292 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 10,180.00p - 15,730.00p |
| Market Capitalisation: | £191.75b |
| VWAP: | 12,407.0901p |
| Shares in Issue: | 1.55b |
Astrazeneca (AZN) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 11 | 12,438.75785p | SI Trade Currency Conversion |
07:25:02 - 15-Jul-26 |
| Unknown* | 1 | 12,287.27499p | SI Trade Currency Conversion |
06:48:25 - 15-Jul-26 |
| Unknown* | 4 | 12,349.95755p | SI Trade Currency Conversion |
06:00:22 - 15-Jul-26 |
| Unknown* | 0 | 12,349.95755p | SI Trade Currency Conversion |
05:05:10 - 15-Jul-26 |
| Unknown* | 0 | 12,446.96628p | SI Trade Currency Conversion |
00:25:43 - 15-Jul-26 |
| Unknown* | 0 | 12,446.96628p | SI Trade Currency Conversion |
23:27:14 - 14-Jul-26 |
| Unknown* | 0 | 12,434.28052p | SI Trade Currency Conversion |
23:03:56 - 14-Jul-26 |
| Unknown* | 0 | 12,356.67354p | SI Trade Currency Conversion |
21:40:50 - 14-Jul-26 |
| Unknown* | 0 | 12,446.96628p | SI Trade Currency Conversion |
21:31:09 - 14-Jul-26 |
| Unknown* | 41 | 12,293.99098p | Currency Conversion OTC Trade |
21:30:50 - 14-Jul-26 |
Astrazeneca (AZN) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 14th Jul 2026 7:00 am | RNS | AstraZeneca licenses novel EGFR inhibitor |
| 9th Jul 2026 7:00 am | RNS | Update on CARDIO-TTRansform Phase III trial |
| 1st Jul 2026 3:05 pm | RNS | Admission of Further Securities to Trading |
| 1st Jul 2026 3:00 pm | RNS | Total Voting Rights |
| 29th Jun 2026 7:30 am | RNS | Enhertu approved in EU for HER2+ solid tumours |
| 29th Jun 2026 7:00 am | RNS | Datroway recommended for approval in EU for TNBC |
| 15th Jun 2026 7:00 am | RNS | Truqap approved in US for prostate cancer |
| 1st Jun 2026 3:05 pm | RNS | Admission of Further Securities to Trading |
| 1st Jun 2026 3:00 pm | RNS | Total Voting Rights |
| 29th May 2026 7:00 am | RNS | Imfinzi approved in US for early bladder cancer |